نتایج جستجو برای: Divalent antibody

تعداد نتایج: 174425  

2016
Hongyu Zhao Ao Shen Yang K. Xiang David P. Corey

We describe three recombinant engineered antibodies against three recombinant epitope tags, constructed with divalent binding arms to recognize divalent epitopes and so achieve high affinity and specificity. In two versions, an epitope is inserted in tandem into a protein of interest, and a homodimeric antibody is constructed by fusing a high-affinity epitope-binding domain to a human or mouse ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2007
Pierre-Yves Brard Habibe Karacay Rhona Stein Robert M Sharkey M Jules Mattes Chien-Hsing Chang Edmund A Rossi William J McBride David M Goldenberg

PURPOSE Bispecific antibody (bsMAb) pretargeting procedures use divalent hapten-peptides to stabilize the binding of the hapten-peptide on tumor cells by a process known as the affinity enhancement system. The goal of this study was to determine if a divalent hapten-peptide could induce apoptosis by cross-linking bsMAb bound to CD20. METHODS Three forms of bsMAbs were prepared by coupling the...

Journal: :The Yale Journal of Biology and Medicine 1969
Richard E. Bryant

In most experimental systems, phagocytosis of bacteria by polymorphonuclear leukocytes (PMN's) is interrupted by divalent cation chelation with Na2H2EDTA.1" This has led to the assumption that divalent cations are required for phagocytosis.' Phagocytic systems, in fact, measure the end result of a complex sequence of events which include interaction of the bacterium with plasma proteins of both...

2005
William R. Church Frances H. Bhushan Kenneth G. Mann

Vitamin K deficiency or administration of vitamin K antagonists results in the biosynthesis of abnormal des-’y-carboxy forms of the vitamin K-dependent proteins. Monoclonal antibody H-i 1 binds several vitamin K-dependent proteins at a determinant that includes the first two residues of ‘y-carboxyglutamic acid. Antibody H-i 1 binds fully carboxylated prothrombin and protein C in the presence of...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2004
Ruiqi Meng Joan E Smallshaw Laurentiu M Pop Michael Yen Xiaoyun Liu Lien Le Maria-Ana Ghetie Ellen S Vitetta Victor Ghetie

PURPOSE The purpose of this study was to prepare chimeric antihuman CD22 tetravalent monoclonal antibodies (MAbs) with high functional affinity, long persistence in the circulation, increased antitumor activity, and conserved effector function in vitro. EXPERIMENTAL DESIGN We investigated the association/dissociation rates of these tetravalent antibodies using CD22(+) Daudi lymphoma cells. We...

Objective(s): Pseudomonas aeruginosa infections such as keratitis are considered among the major health problems worldwide due to the complexity of pathogenesis and antibiotic resistance crisis, thus, finding new effective approaches for prevention and treatment of the infections seem to be still vital. In this report, we aimed to investigate the therapeutic effects of topical administration of...

Journal: :Blood 1989
W R Church F H Bhushan K G Mann E G Bovill

Vitamin K deficiency or administration of vitamin K antagonists results in the biosynthesis of abnormal des-gamma-carboxy forms of the vitamin K-dependent proteins. Monoclonal antibody H-11 binds several vitamin K-dependent proteins at a determinant that includes the first two residues of gamma-carboxyglutamic acid. Antibody H-11 binds fully carboxylated prothrombin and protein C in the presenc...

Journal: :The Journal of Cell Biology 1980
W R Springer S H Barondes

Identification of cell surface molecules that play a role in cell-cell adhesion (here called cell adhesion molecules) has been achieved by demonstrating the inhibitory effect of univalent antibodies that bind these molecules in an in vitro assay of cell-cell adhesion. A more convenient reagent, intact (divalent) antibody, has been avoided because it might agglutinate the cells rather than block...

2016
Julien Beyrath Neila Chekkat Cristian R. Smulski Caterina M. Lombardo Marie-Charlotte Lechner Cendrine Seguin Marion Decossas Maria Vittoria Spanedda Benoît Frisch Gilles Guichard Sylvie Fournel

DR4 (Death Receptor 4) and DR5 (Death Receptor 5) are two potential targets for cancer therapy due to their ability to trigger apoptosis of cancer cells, but not normal ones, when activated by their cognate ligand TRAIL (TNF related apoptosis-inducing ligand). Therapies based on soluble recombinant TRAIL or agonist antibodies directed against one of the receptors are currently under clinical tr...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید